Amino Acids

Evidence overview

L-Theanine

L-theanine is an amino acid from tea, studied across acute cognition, stress, anxiety, and sleep. The research base is moderate in size, dominated by short-duration trials in healthy adults, and often examines L-theanine in combination with caffeine rather than alone. Recent systematic reviews on sleep outcomes have expanded the literature into newer territory.

Or browse all supplements

Most studied for

Coverage pending

PubMed coverage

Coverage pending

Across all indexed goals

Safety profile

In your full report

Adverse events + drug interactions

Mechanism class

Amino acid found primarily in tea leaves. Crosses the blood-brain barrier; modulates glutamate and...

Study coverage

Study coverage by goal

PubMed counts for L-Theanine grouped by the goal each study targets.

Evidence overview is temporarily unavailable for L-Theanine.

Evidence

What the evidence covers

The terrain of the published literature, not its conclusions.

L-theanine is one of the few free amino acids consumed regularly in the diet (via tea) and is a frequent subject of acute-effects research because its onset is fast (under an hour) and its effect profile is easy to measure. The dominant supplemental form in trials is purified L-theanine; combinations with caffeine are the most-studied pairing because the two are co-consumed in tea, and many trials cannot cleanly separate L-theanine effects from caffeine effects.

The outcome dimensions covered most heavily are acute cognitive performance (attention tasks, reaction time, working memory) under stress or fatigue, subjective stress and anxiety markers, mood, and more recently sleep quality. The most-studied populations are healthy young adults, with smaller research streams in clinical anxiety, ADHD, and aging-related cognitive decline. The shorter-than-typical trial durations (single-dose, hours-to-days) reflect the supplement's acute pharmacology rather than a research-quality gap.

Demographically the literature skews toward healthy young adults and university student populations, which is a known limitation when generalizing to older adults, people with diagnosed anxiety disorders, or chronic-stress populations. The newer 2024-2025 sleep meta-analyses extend the literature into longer trial designs and more diverse demographic samples but are still building toward demographic balance.

Safety

Safety summary

Common adverse events, drug interactions, and special populations.

L-theanine has an unusually clean safety profile and is GRAS-listed by the FDA. The most-reported side effects in clinical trials are mild headache and gastrointestinal discomfort, both at low frequencies. There is no established tolerable upper limit and dietary intake from tea has been consumed for centuries without identified harm. Drug interactions are limited: theoretical additive effects with antihypertensive medications and CNS depressants have been described but rarely documented in trials at supplement doses. People with low blood pressure or those on stimulant or sedative medications should consult a clinician.

This summary is informational and not medical advice. Consult a clinician before starting or changing any supplement, especially if you take prescription medications.

Foundations

Foundation of the evidence base

A few studies the field anchors on. Not the full picture, just the starting points.

  • Systematic review and meta-analysisNutrition Reviews, 2025n=Pooled RCT data across cognition, sleep, and mood outcomes

    Recent comprehensive synthesis of L-theanine's effects across cognition, mood, and sleep, both alone and in caffeine combinations. The breadth and recency make it the current supplement-overall reference, superseding earlier single-outcome MAs.

    View on PubMed
  • Systematic review and meta-analysisSleep Medicine Reviews, 2025n=Pooled RCT data across L-theanine sleep trials

    Most recent specialty synthesis on L-theanine and sleep outcomes, published in the highest-impact sleep-medicine specialty journal. The field's anchor for the newer wave of L-theanine-for-sleep research.

    View on PubMed
  • Systematic reviewPlant Foods for Human Nutrition, 2020n=Synthesis of L-theanine stress and anxiety trials

    L-theanine-specific systematic review on the stress and anxiety use case, which is the primary marketed and consumer-facing use of the supplement. Establishes the reference document for this specific application.

    View on PubMed

Limitations

What this page doesn't answer

Where the public summary stops and the personalized report begins.

This page summarizes the L-theanine literature at a general level. It does not address what dose is appropriate for your specific goal (acute stress vs. sleep onset vs. chronic anxiety), whether you would benefit more from L-theanine alone or in a combination, how L-theanine interacts with your medications, or whether your baseline tea consumption already provides a meaningful dose. The personalized report incorporates those details.

Personalized to you

Get a personalized L-Theanine report

Your free first report adds the things this page doesn't: per-goal evidence breakdown, demographic-specific findings, full citation list, and a safety section tailored to your profile.

Free first report. No credit card. Cancel anytime.

Get notified when new evidence appears

We'll email you when the literature on L-Theanine materially updates. No account required.